Tuesday November 9 2021 COVID19 Precautions Vaccines and Treatments for Transplant Recipients bmtinfonetorg 8885977674 helpbmtinfonetorg Many thanks to Incyte for its support of this webinar ID: 934493
Download Presentation The PPT/PDF document "Hosted by Blood & Marrow Transpla..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Hosted by
Blood
& Marrow Transplant Information Network (BMT InfoNet)Tuesday November 9, 2021
COVID-19: Precautions, Vaccines and Treatments for Transplant Recipients
bmtinfonet.org ✦ 888-597-7674 ✦ help@bmtinfonet.org
Many thanks to Incyte for its support of this webinar
.
Slide2COVID-19: Precautions, Vaccines, and Treatments for Transplant Recipients
Alyssa R. Letourneau MD, MPH
Areej El-Jawahri MDMassachusetts General HospitalClick to add text
Slide3Outline
Update on state of the nation with COVID-19
COVID-19 in Transplant RecipientsVaccine Recommendations in Transplant RecipientsHow to Treat COVID-19 in Transplant RecipientsCommon Myths about COVID-19
Slide4COVID-19
COVID-19 is the clinical disease caused by SARS-COV-2 virus
First identified in 2019, there are now over 219 million cases worldwide
Slide5COVID-19
As of 11/6/2021: 46,358,362 cases US,
749,846 deathsApproximately 75,000 new cases per day in the United States now
Slide6COVID-19
Slide7COVID-19 in Transplant Recipients
Multiple studies since the beginning of the pandemic with relatively consistent findings:
75%-80% transplant recipients are hospitalized with COIVD-1921% have severe illness Mortality: 22-35% mortalityHigher risk of COVID-19 hospitalization and mortality in patients with blood cancers
Slide8COVID-19 in Transplant Recipients
Risk factors for worse outcomes:
Older age > 40 years, male recipientsFirst year post-transplantBeing treated with immunosuppressionPoor performance statusRecent receipt of anti-cancer treatment in the past yearPatients who are > 2 years out from transplant and off immunosuppression similar risk to general population
Slide9COVID-19 in Transplant Recipients
Several complications have been reported post COVID-19 infection in transplant recipients
Blood clotsKidney and liver problemsInflammation of heart muscle (myocarditis)Post-acute COVID-19 syndromeExacerbation of graft-versus-host disease (GVHD) symptoms?
Slide10Vaccine Recommendations in Transplant Recipients
Patients should receive COVID-19 vaccine > 3 months after autologous stem cell transplantation
Allogeneic stem cell transplantation recipients should discuss with their doctor, they may delay vaccines until 4-6 months post-HCTVaccine response lower in transplant recipients compared to normal population
Slide11Available Vaccines
mRNA Vaccines
Pfizer-BioNTechModernaNon-replicating viral vector vaccineJohnson & Johnson / Janssen (J&J)
Slide12Do These Vaccines Work?
Yes!
They are about 94-95% effective (especially mRNA vaccines)Studies have shown that these vaccines are also effective in immunocompromised patients (70-80% effective)Some data to suggest better response to the mRNA vaccines (Pfizer & Moderna) in transplant recipients
Slide13Are These Vaccines Safe?
Yes!
There are common side effects and rare adverse eventsLocal reaction: pain at injection site, localized swelling, resolves within a few daysSystemic reaction: fatigue, headache, muscle pain, chills, and joint pains, resolves within a few daysRare adverse reactions: blood clots (J&J), myocarditis (Moderna/Pfizer), very rare
Slide14Vaccine Recommendations in Transplant Recipients
Third dose has been shown to increase immunity to COVID-19
Who should get a booster / additional dose?65 years of age or olderTransplant recipients who are < 2 years from transplantTransplant recipients with chronic GVHD or those on immunosuppression Patients can mix and match between vaccines for boosterRegardless of the above, if you got J&J you should get a booster consider getting Moderna or Pfizer for your booster post-transplant
Slide15How to protect yourself and others?
Wear a mask in public settings!! Regular masks are fine
Get vaccinated, these vaccines are safe and effectiveImmunocompromised patients should get a booster vaccineMake sure your family, kids, and friends get vaccinated
Slide16COVID-19 Treatment
Mild to moderate disease – outpatient setting
Supportive care to help relieve symptoms. People with mild symptoms can recover at homeMonoclonal antibodies: beneficial especially in patients at risk for severe illness (i.e., transplant recipients), helpful as early as possible in the illness course (ideally < 7 days)Promising new oral antiviral Paxlovid (Pfizer): very promising!
Slide17COVID-19 Treatment
Moderate to severe disease – hospitalized patients
Remdesivir – for COVID-19 requiring hospital stayDexamethasone: decrease risk of dying in hospitalized patients with COVID-19 on oxygenOther agents to reduce systemic inflammation have been used with mixed results. Unclear if/how these agents help patients who are already immunosuppressedMonoclonal antibodies: sometimes used on a case-by-case basis for patients not mounting their own response.
Slide18Myths about COVID-19
Myth
AnswerI would like to take hydroxychloroquine or azithromycin to treat or prevent COVID-19Data have shown that these drugs are simply not effectiveI worry about the long-term effects of getting the COVID-19 vaccineNo data to support long-term effects of vaccination. Long-term effects of the COVID-19 virus are likely much worse.
Colin Powell was vaccinated and still died of COVID-19. There is no point in getting the vaccine.Patients who are very immunocompromised may not respond to the vaccine, but even a little bit of protection is better than nothing. I am so immunocompromised, there is no point in getting the vaccine.Studies have shown that even patients who are immunocompromised are getting some protection from the vaccine. Discuss with your doctor.
Slide19Additional Questions about COVID-19
Question
AnswerWhere should my antibody level be? Should I have it tested?It’s not clear what antibody level provides protection. We advise against antibody testing outside clinical trials. Will we need ongoing boosters / additional vaccines?Unknown at this time, but it seems likely.
I have had COVID-19, should I get the vaccine?Yes! Studies suggest that protection from the vaccine is stronger and longer lasting than immune protection from the virus.
Slide20Centers for Disease Control (CDC):
https://www.cdc.gov/coronavirus/2019-ncov/index.html
How to protect yourself from the CDC: https://www.cdc.gov/coronavirus/2019-ncov/prepare/prevention.htmlCOVID-19 Questions – Immunization Action Coalition / Ask the experts: https://www.immunize.org/askexperts/experts_cov.aspResources